Corporate News

CFO Dr Jan Wicke: 9M 2021 results "A sign of our resilience and strength"

Talanx achieved a very good Group net income of EUR 723 million for the first nine months. The Group is thus fully on track to achieve its annual target of EUR 900 to 950 million – it is now even expected to close the 2021 financial year at the upper end of this range.

CFO-Wicke-GJ-Videostatement

The Group was able to achieve this result despite the considerable large loss burden, especially in the third quarter. The flood catastrophe in Western Europe alone led to gross claims of more than EUR 1 billion. "The fact that we were able to handle this well is a sign of our resilience, our strength," says CFO Dr Jan Wicke in the video on the quarterly and 9M results.

In his video, Dr Wicke also provides insights into why the impact of the coronavirus pandemic has mostly normalised over the year so far and in which divisions Corona still remains a central issue. In the video there will also be an initial outlook on the goals for financial year 2022.


Disclaimer

This news release contains forward-looking statements which are based on certain assumptions, expectations and opinions of the Talanx AG management. These statements are, therefore, subject to certain known or unknown risks and uncertainties. A variety of factors, many of which are beyond Talanx AG’s control, affect Talanx AG’s business activities, business strategy, results, performance and achievements. Should one or more of these factors or risks or uncertainties materialise, actual results, performance or achievements of Talanx AG may vary materially from those expressed or implied in the relevant forward-looking statement. Talanx AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does Talanx AG accept any responsibility for the actual occurrence of the forecasted developments. Talanx AG neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.